Company Filing History:
Years Active: 2022
Title: Innovations of Xiaofeng Zhu in Probiotic Technology
Introduction
Xiaofeng Zhu is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of microbial technology, particularly in the development of composite probiotics. With a total of 2 patents, his work focuses on alleviating metabolic syndrome through innovative probiotic compositions.
Latest Patents
Xiaofeng Zhu's latest patents include "Composite probiotics and use thereof" and "Probiotic composition and use thereof." The first patent discloses a composite of probiotics consisting of CCFM8630, CCFM8631, CCFM1044, and CCFM711. This combination has shown a significantly better effect in alleviating metabolic syndrome compared to individual probiotics or combinations of two. The results indicate improvements in lowering serum low-density lipoprotein, total cholesterol, and liver triglyceride levels, among other health benefits. The second patent presents a probiotic composition made up of CCFM8630, CCFM8631, and CCFM1044, which also demonstrates superior effects in managing metabolic syndrome, including reductions in fasting blood glucose levels and improvements in liver antioxidant capacity.
Career Highlights
Xiaofeng Zhu is currently employed at Infinitus (China) Company Ltd. His work at this company has allowed him to focus on innovative research in the field of probiotics, contributing to advancements that have the potential to improve public health.
Collaborations
Xiaofeng Zhu collaborates with notable colleagues, including Yuanyuan Wang and Wei Feng Chen. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Xiaofeng Zhu's innovative work in probiotic technology showcases his commitment to improving health outcomes through scientific advancements. His patents reflect significant contributions to the understanding and application of probiotics in managing metabolic syndrome.